FDA approves first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumours

Read more

SII launches rotavirus vaccine Rotasiil

Read more

Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall

Read more

US FDA completes inspection of Alembic’s JV firm Aleor Derma’s Karakhadi unit

Read more

Strides Pharma Science appoints Dr R Ananthanarayanan as CEO & MD

Read more

ISPE announces Tim Howard as interim CEO & President

Read more

BioAsia to promote innovations in healthcare through ‘Start-up Stage’

Read more

Drug developers take fresh aim at ‘guided-missile’ cancer drugs

Read more

GSK credits STEER for Horlicks technology after year long IP Battle

Read more

Merck’s Keytruda shows mixed results in phase 3 trial for small cell lung cancer

Read more